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LES R&D-DSP Technologies, Visp, SwitzerlandABSTRACT RADARADARADARADA (RADA 16-I) is a synthetic amphiphilic peptide designed to self-assemble in a controlled
way into fibrils and higher ordered structures depending on pH. In this work, we use various techniques to investigate the state of
the peptide dispersed in water under dilute conditions at different pH and in the presence of trifluoroacetic acid or hydrochloric
acid. We have identified stable RADA 16-I fibrils at pH 2.0–4.5, which have a length of ~200–400 nm and diameter of 10 nm. The
fibrils have the characteristic antiparallel b-sheet structure of amyloid fibrils, as measured by circular dichroism and Fourier
transform infrared spectrometry. During incubation at pH 2.0–4.5, the fibrils elongate very slowly via an end-to-end fibril-fibril
aggregation mechanism, without changing their diameter, and the kinetics of such aggregation depends on pH and anion
type. At pH 2.0, we also observed a substantial amount of monomers in the system, which do not participate in the fibril
elongation and degrade to fragments. The fibril-fibril elongation kinetics has been simulated using the Smoluchowski kinetic
model, population balance equations, and the simulation results are in good agreement with the experimental data. It is also
found that the aggregation process is not limited by diffusion but rather is an activated process with energy barrier in the order
of 20 kcal/mol.INTRODUCTIONIn nanotechnology several functional materials are designed
based on the spontaneous self-assembling of single building
blocks into highly organized structures (1–3). This bottom-
up approach involves a reduction of the total free energy of
the system through a combination of weak and strong intra-
and intermolecule interactions such as hydrogen forces,
ionic bonds, and hydrophobic interactions (4).
Ionic complementary peptides represent a family of
monomers able to spontaneously self-assemble in aqueous
solutions (5–9). These short, synthetic oligopeptides of
8–16 amino acid residues are either inspired by fragments
of naturally occurring proteins or are de novo designed.
The peculiar structure of the macromolecules displays on
one side completely hydrophobic residues and on the other
side positively and negatively charged residues arranged
alternatively. Based on charge distributions, one can classify
the ionic-complementary peptides into different types: type
I: þ, type II:  þþ, type III:   þþþ, and type IV:
   þþþþ (6). Depending on the intrinsic properties
of the structure (e.g., amino acid periodicity, charge distri-
bution, intrinsic chirality, etc.), different peptides have
different propensity to form inter- and/or intramolecular
hydrogen bonds (6,10), thus leading to different secondary
structures (a-helix, b-sheet, or random coil) (11,12) and
aggregation states (13). These characteristics make the
self-assembly of amphiphilic peptides particularly attrac-
tive. For example, one can sensitively tune the charge prop-
erties of the peptides, by modifying either their intrinsic
structure or the environmental conditions (pH, ionicSubmitted November 9, 2011, and accepted for publication March 2, 2012.
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0006-3495/12/04/1617/10 $2.00strength, etc.), to produce in a controlled way various stable
and resistant nanomaterials. These include fibrils (4),
various types of fibril networks (6), gels (i.e., hydrogels
with extremely high water content) (14), and membranes
(15). Potential applications have been found for such bio-
compatible materials in medicine, biotechnology, nanotech-
nology, and biology. Examples include three-dimensional
cell culture (5,16–18), tissue repairing and engineering
(15,19,20), cosmetic industry (21), drug release and drug
delivery (6,22,23), biological surface engineering (24,25),
separation matrices (15), and membrane protein stabiliza-
tion (3,5). Moreover, self-complementary peptides represent
a useful model system to investigate the in vitro formation of
amyloid fibrils involved in several neurodegenerative
diseases (26).
RADARADARADARADA (RADA 16-I) is a peptide of
16 amino acid residues, belonging to the family of self-
complementary peptides. It consists of repeated segments
of hydrophobic (alanine) and hydrophilic (arginine and
aspartic acid) amino groups (27). RADA 16-I has a high
propensity to self-assemble to form very stable b-sheet
structures, leading to a series of organized structures. For
example, under acidic pH conditions, nanofibrils are
observed, whereas higher order nanofibril scaffold are ob-
tained by increasing pH or adding salt (27). RADA 16-I
hydrogels with extremely high water content are ideal mate-
rials for making three-dimensional scaffolds for cell culture
and tissue engineering (16,17). Although significant atten-
tion has been given in the literature to the application of
RADA 16-I hydrogels, only a few fundamental studies
can be found focusing on the aggregation (self-assembling)
mechanism (10,27).doi: 10.1016/j.bpj.2012.03.012
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mechanism is interesting not only academically but also in
practical applications. An example involves the stability of
the dispersion of assembled RADA 16-I fibrils, which still
limits their industrial productions and handling. Due to the
large aggregation propensity, avoiding RADA 16-I assem-
bling into fibrils is extremely difficult. A completely molec-
ular solution of RADA 16-I has in fact never been observed
in the literature, and its fibril dispersions represent the start-
ing materials for obtaining scaffolds and gels in practical
applications. Moreover, such applications require well-
controlled stability of the fibril dispersions to assemble
them into desired higher ordered structures.
In this work, we identify the existence of stable fibril units
of RADA 16-I at low pH. During their incubation, such
fibrils elongate to longer fibrils through end-to-end fibril-
fibril association. Several biophysical techniques have
been applied to characterize the system. Fibrils size and
morphology were characterized by atomic force microscopy
(AFM), cryo-scanning electron microscopy (cryo-SEM),
transmission electron microscopy (TEM), dynamic light
scattering (DLS), and static light scattering. The fraction
of RADA 16-I monomers in the system was quantified by
size exclusion chromatography (SEC), whereas protein
secondary structure was analyzed by circular dichroism
(CD) and Fourier transform infrared spectrometry (FTIR).
Using such comprehensive characterizations, the stability
behavior of the fibril dispersions is investigated as a function
of several parameters, such as pH, anion type, and
temperature.MATERIAL AND METHODS
Material
The RADA 16-I (Ac-R-A-D-A-R-A-D-A-R-A-D-A-R-A-D-A-NHCOCH3)
peptide was provided by Lonza Ltd. (Visp, Switzerland) as lyophilized
powder in the form of chloride and trifluoroacetic salt. The material was
used as receivedwithout further purification. To prepare the startingmaterial
for our investigations, we weighted the peptide powder on a high precision
balance (UMT5 Comparator, Mettler Toledo, Greifensee, Switzerland).
We then added a suitable amount of buffer solution, followedbymild shaking
for 10 min for homogenization. The peptide concentration in the dispersion
was measured by ultraviolet (UV) absorbance at 217 nm, and the UVextinc-
tion coefficient at 217 nm was estimated equal to 6600 mL/g/cm. For each
sample, at least three repetitions were carried out for the concentration
measurement. It is worth noticing that for all the experiments shown in
this work very similar results have been obtained from three different
production batches, with the peptide in the form of both chloride and
trifluoroacetic salts.AFM
10 mL of 150-fold diluted samples were spotted onto a freshly cleaved mica
surface for 30 s before washing with Milli-Q deionized water to remove
unattached materials and gently drying under nitrogen flux. Samples
were imaged at room temperature by a Nanoscope IIIa (Digital Instruments,
Tonawanda, NY) operating in tapping mode. A scan rate of 0.8 Hz and anti-Biophysical Journal 102(7) 1617–1626mony-doped silicon cantilevers with resonance frequency in the range
325–382 kHz and tip radius of 8 nm (Veeco, Plainview, NY) were used.Electron microscopy
Samples for cryo-SEM were vitrified at about -160C and transferred via
the BAL-TEC airlock shuttle system VCT 100 to the freeze-etching unit
BAF 060 from BAL-TEC (Balzers, Liechtenstein), where the continuous
phase was sublimated under high vacuum at 80C (within ~120 min)
followed by coating with tungsten (2 nm, at 10 angle). Images were
recorded on a Gemini 1530 FEG scanning electron microscope (Zeiss,
Oberkochen, Germany) equipped with a cold stage.
Samples for TEM were loaded onto a carbon grid (Quantifoil, Jena,
Germany) and negative stained with a 2% uranyl acetate aqueous solution.
Pictures were recorded on a FEI Morgagni 268.Light scattering
DLS and static light scattering measurements were performed online using
a goniometer, BI-200SM (Brookhaven Instruments, Holtsville, NY)
covering angles from q ¼ 16 to 150. A solid-state laser, Ventus LP532
(Laser Quantum, Manchester, UK) with a wavelength l0 ¼ 532 nm was
used as the light source.
DLS was also measured at a fixed angle of q ¼ 173 using a Zetasizer
Nano (Malvern, Worcestershire, UK) with a laser beam wavelength of
l0 ¼ 633 nm. Micro UV-cuvettes with dimension 12.5  12.5  45 mm
(70 mL) and light path 1 cm (Brand GmbH, Wertheim, DE) were used.
DLS measures the intensity fluctuation due to the Brownian motion of
the particles as a function of the delay time, t, from which the intensity
autocorrelation function g2ðtÞ and the field autocorrelation function g1ðtÞ
can be defined
g2ðtÞ ¼ hIðq; 0ÞIðq; tÞihIðqÞi2 ; (1)
g2ðtÞ ¼ 1þ sg1ðtÞ2; (2)
where s is a constant close to 1, depending on the specific configuration of
the detector, and q is the scattering wavevector, q ¼ ð4pn=l0Þsinðq=2Þ,
with q the scattering angle, n the refractive index of the solvent, and l0
the wavelength of the laser beam. The field autocorrelation function decays
exponentially with t (28):
g1ðtÞ ¼ expðGtÞ; (3)
where the decay rate coefficient, G, is a function of the particle diffusivity.SEC
SEC was performed with a Superdex Peptide 10/300 GL, 10 mm 300 mm
size-exclusion column (GE Healthcare, Uppsala, Sweden) mounted on an
Agilent 1100 series HPLC unit (Santa Clara, CA) consisting of a quaternary
pump with degasser, an autosampler, a column oven, and a DAD detector.
Each sample was eluted for 70 min at a constant flow rate of 0.4 mL/min
using as mobile phase the same buffer of the analyzed sample. The UV
absorbance peaks were detected at 217 nm.CD
CD spectra were collected using a Jasco-815 CD spectrophotometer (Jasco,
Easton, MD). Far-UV CD spectra were recorded from 260 to 190 nm with
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0.1 cm path length was used. Spectra obtained after buffer subtraction was
corrected for protein concentration and smoothed using the Savitsky-Golay
function.FTIR
Hydrated thin film attenuated total reflectance (ATR-FTIR) measurements
were performed on a Nicolet Nexus 870 FTIR ESP instrument equipped
with an ATR Nicolet Omni-Sampler device (Nicolet, Madison, WI).
Aliquots of 10 mL were spotted on the crystal surface and left to dry under
nitrogen flux. The spectra were collected in the wavelength range from
1700 to 1600 cm1 at 1 cm1 resolution and smoothed using the Savit-
sky-Golay function after buffer subtraction.RESULTS AND DISCUSSION
Characterization of fibril size and morphology
After the peptide powder is dissolved in water at a concentra-
tion in the range of 0.5–1 g/L, a transparent homogeneous
solution is obtained (see Fig. S1 in the Supporting Material).
The AFM analysis in Fig. 1 a shows the presence of a signif-
icant amount of nanoscale fibrils with length in the range of
~200–400 nm, which is consistent with previous findings in
the literature (27). Notably, the obtained fibrils cannot be
further broken by either sonication or shaking or stirring,
indicating that these short fibrils exhibit high resistance
against shearing forces.
Three different solvents were used to dissolve the peptide:
Milli-Q deionized water (pH was automatically shifted to
around 4.5 due to the counterions of the lyophilized
peptide), 0.013 M trifluoroacetic acid (TFA) solution at
pH 2.0 and 0.01M hydrochloric acid (HCl) solution at pH2.0. In each solution, the fibril length distribution was eval-
uated from the AFM pictures by manually counting and
measuring the length of the fibrils. Under each condition
at least three independent samples and 350 fibrils were
considered to ensure statistical reliability. Fig. 1 b shows
the fibril length distributions in the three solutions at the
peptide concentration of 1 g/L. All the distributions are
rather similar in shape but the average length is slightly
dependent on pH. The mean length and the standard
deviation of the fibril distributions are respectively 296
and 5131 nm in water at pH 4.5, 370, and 5134 nm in
TFA solution at pH 2.0, 332, and5138 nm in HCl solutions
at pH 2.0.
To obtain more details on the fibril structure, we have
analyzed the samples using both cryo-SEM and TEM. As
shown in Fig. 1, c and d, both techniques confirm the length
distribution obtained from AFM. The fibril diameter in all
the considered solutions is ~14 nm according to AFM and
cryo-SEM pictures and ~10 nm according to TEM pictures.
It is well known that due to the excluded volume of the AFM
tip during the tipping of the surface, the fibril diameter
measured by AFM cannot be considered reliable. Moreover,
the drying procedure necessary during sample preparation
for AFM and cryo-SEM analysis could induce flattening
of the fibril structure on the surface. Because TEM requires
very mild drying conditions, the fibril diameter given by
TEM can be considered the most reliable. However, also
in this case the staining technique could affect the results.
Therefore, a detailed model of the peptide fibrils cannot
be obtained with any of the applied techniques.
It is known that the length and the height of a RADA 16-I
peptide in a stretched conformation are equal to 5 andFIGURE 1 (a) Typical AFM picture showing the
presence of nanofibrils in the dispersions. (b) Fibril
length distribution obtained from AFM pictures, in
the freshly prepared peptide dispersion in several
aqueous solutions. (c and d) Cryo-SEM (c) and
TEM (d) pictures of the fibrils in the aqueous
dispersions of the RADA 16-I lyophilized powder
at pH 4.5 and concentration of 0.5 g/L.
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FIGURE 2 (a) Decay coefficient of the DLS measurements, G, as a func-
tion of the wavevector, q2, measured using BI-200SM (Brookhaven) (>)
and Nanosizer (Malvern) (B). The continuous line is the best fit of G ¼
D$q2 with D ¼ 6.6 mm2/s. (b) Measured autocorrelation functions at the
angles, 60 (B), 90 (,), 120 (D), and 150 (>), compared with the
computed ones using Eq. 3 (continuous line).
1620 Arosio et al.1.3 nm, respectively (27). On the basis of the mechanism
proposed in the literature (6,13), the peptides form the fibrils
by aggregation along their stretched backbone via hydrogen
bonding. In this way, the obtained fibrils would have a width
or diameter of ~5 nm, which is only half of the value deter-
mined from TEM in Fig. 1 d. On the other hand, the fibrils
could also further assemble by lateral association into thicker
fibrils (13). The observed width or diameter of 10 nm would
then indicate that the observed fibril is composed of two
fibrils joined together by lateral association. No twisting of
the fibrils occurs, according to the TEM picture in Fig. 1 d.
The height of the fibrils has been evaluated from the AFM
pictures equal to 1.16 5 0.22 nm, rather consistent with
the height of the RADA-I peptide.
In parallel with microscopy analysis, the fibrils size was
analyzed by light scattering (LS) techniques. For an asym-
metric particle, the decay rate coefficient, G, of the field
autocorrelation function in dynamic LS is composed of
two terms: one related to the translational diffusion (D)
and another to the rotational motion of the particle along
its axis (Q) (29):
G ¼ D$q2 þQ: (4)
The decay rate coefficient G has been evaluated with two
different instruments at different angles and plotted in
Fig. 2 a as a function of q2. This shows that all the data
can be well represented by a straight line with a negligible
intercept (i.e., Q~0), indicating that for the given fibril
system, the contribution of the rotational diffusion is negli-
gible. The estimated translational diffusion coefficient is
D ¼ 6.6 mm2/s.
Let us assume that the short RADA 16-I fibrils are rigid
and rod-like. The fibril dimension can then be estimated
from the translational diffusion coefficient according to
the Doi-Edward relationship (30):
D ¼ kT
3phL
ln

L
b

; (5)
where k is the Boltzmann constant, T the temperature, h
the solvent viscosity, L and b the length and the diameter
of the fibril, respectively. For a polydisperse system, the
measured diffusion coefficient is a z-average value, hDiz,
which can be computed from the length distribution of
individual fibrils (31):
hDizðqÞ ¼
PN
i¼ 1
Ni$Di$PiðqÞ$L2i
PN
i¼ 1
Ni$PiðqÞ$L2i
; (6)
where Ni is the number concentration of fibrils with length
Li and Pi(q) is the form factor for a rigid rod with length
Li at the wavevector q, given by (32):Biophysical Journal 102(7) 1617–1626PiðqÞ ¼ 2
qLi
ZqLi
0
sinðxÞ
x
dx 

2
qLi
sin

qLi
2
2
: (7)
From the fibril length distributions determined from AFM in
Fig. 1 b and the Di values of individual fibrils computed
from Eq. 5 considering b ¼ 10 nm, we have calculated the
hDiz value from Eq. 6. The obtained hDiz values are only
slightly dependent on the scattering angle: 7.9 mm2/s at
173 and 7.7 mm2/s at 60, and are reasonably in agreement
with the value (6.6 mm2/s) from the DLS measurement. As
a consequence, from the calculated hDiz values we can
predict the autocorrelation function at different angles,
and the obtained results are compared to the measured
ones in Fig. 2 b. As can be seen, the agreement is rather
satisfactory. The difference at large delay times occurs
because we have used a single G value in the autocorrelation
function simulations, without accounting for the polidisper-
sity of the samples.
Given the low peptide concentration (0.5–1 g/L), we can
consider the fibril dispersions as dilute systems. The form
factor of the fibrils, P(q), can then be determined from the
Self-Assembly of RADA Nanofibrils 1621static LS experiments, i.e., from the measured intensity at
different angles, I(q) (33):
PðqÞ ¼ IðqÞ
Ið0Þ; (8)
where I(0) is the intensity at zero angle.
For an ensemble of polydisperse rods, the average
form factor, hP(q)i, can then be expressed using Eq. 7 as
follows (34):
hPðqÞi ¼
PN
i¼ 1
Ni$PiðqÞ$L2i
PN
i¼ 1
Ni$L2i
: (9)
Using the fibril length distribution in Fig. 1 b, we have
computed the average form factor, hP(q)i, from Eqs. 7 and
9, and the result is compared with the measured hP(q)i in
Fig. 3. It can be seen that the calculated hP(q)i represents
well the experimental data.
The radius of gyration of a rigid rod can be calculated
from its length, as R2g ¼ L2=12 (33). Thus, the average
radius of gyration of our fibrils, hRgi, can also be computed
from the known fibril length distribution in Fig. 1 b, using
the following expression (35):

Rg
	2 ¼
PN
i¼ 1
Ni$R
2
g;i$L
2
i
PN
i¼ 1
Ni$L2i
: (10)
The obtained value is hRgi ¼ 125 nm, which is in good
agreement with that estimated from the form factor based
on the Guinier plot (114 nm). Therefore, the in situ LS
measurements correlate well with microscopy characteriza-
tions and also confirm the reliability of the measured fibril
length distributions in Fig. 1 b.FIGURE 3 Average form factor, hP(q)i of the fibrils, measured by static
light scattering (symbols), compared with the calculated one (solid curve)
according to Eq. 9.It is difficult to determine whether or not the monomeric
form of the peptide is present in the system using LS tech-
niques, because of the substantial difference in size between
the monomers and the fibrils. The size of the monomers
is also below the lower limit of the used microscopy tech-
niques. Thus, we have applied SEC to quantify the mono-
mers. Different cutoff (20 nm and 220 nm) filters were
applied to prepare the samples to verify that no artifacts
were induced by the filtering procedure. It is found that in
the aqueous solution at pH 4.5 no monomer can be detected,
whereas at pH 2.0, apart from the fibrils, we have observed
605 25% monomers both in the TFA as well as in the HCl
solution. It is worth noticing that the amount of monomers
determined by SEC at low pH varies significantly even
though the same preparative procedure was rigorously
followed for several repetitions. This is likely due to the
difference in the fibril length distributions of different resus-
pensions of the same powder even at the same concentra-
tion. In fact, the distributions reported in Fig. 1 b are the
average of different resuspensions. At a given peptide
concentration, samples with a shorter average size contain
more fibrils than those with a larger average size, thus pos-
sessing more fibril ends from which the monomers can
detach. An undetectable amount of monomers at pH 4.5 in
the aqueous solution was confirmed by several repetitions.
From the previous results, we can then conclude that all
the peptides in the original powder are practically in the
form of fibrils, and the presence of monomers at low pH
is likely due to the dissolution of the fibrils. It is in fact
well known that TFA is able to dissolve protein aggregates
into monomers by disrupting the hydrogen bonds (36). From
our present results, we see that HCl can also be used for the
same purpose.
To better understand the state of the peptides under
different conditions, we have investigated their secondary
structure both in the solution and in the original powder,
using FTIR and CD. Due to the well-known interference
between TFA and protein in the I-amide region, the peptide
dispersion in the TFA solution was not analyzed by FTIR. In
Fig. 4 a the FTIR spectra of the peptide in water at pH 4.5
and in the original powder are shown. They are rather
similar and show a maximum at 1627 cm1, characteristic
of the b-sheet structure. A significant shoulder in the range
of 1650–1670 cm1 indicates the presence of b-sheet turn
structures, as observed in other amphiphilic peptide systems
(37). These results suggest that the peptides in water at pH
4.5, as well as in the original powder, possess an ordered
structure, i.e., fibrils, thus confirming that the monomers
at pH 2.0 come from dissolution of the fibrils.
Fig. 4 b shows the CD spectra of the peptide dispersion in
water at pH 4.5 and in the 0.013 M TFA solution at pH 2.0.
For the former, the minimum at 215 nm clearly indicates the
b-sheet structure, thus consistent with the FTIR data. For the
latter, instead, the minimum is located at 200 nm, character-
istic of random coil, more disordered structures. Since inBiophysical Journal 102(7) 1617–1626
FIGURE 4 (a) FTIR spectra of the lyophilized RADA 16-I powder (-)
and its dispersion in water at pH 4.5 (B), and (b) CD spectra of the RADA
16-I dispersion in the 0.013M TFA solution at pH 2.0 (dashed curve) and in
water at pH 4.5 (solid curve).
FIGURE 5 Time evolution of the average hydrodynamic radius, hRhi, of
the fibrils in the 0.013 M TFA solution at pH 2.0 (-), in the 0.01 M HCl
solution at pH 2.0 (:), and in distilled water at pH 4.5 (A), measured at
25C and peptide concentration of 1 g/L.
1622 Arosio et al.this case the monomers are present, this result indicates that
the monomers exhibit a random coil structure in the aqueous
solution. The shoulder around 215 nm corresponds to the re-
maining fibrils. According to CDpro analysis (see Table S1),
the amount of b-strand is 65.5% at pH 4.5 and 13.2% at pH
2.0, whereas the unordered structure content is 10% at pH
4.5 and 66.1% at pH 2.0.Stability and aggregation kinetics
We have monitored the stability of the fibril dispersions at
room temperature in three aqueous solutions: water at pH
4.5, 0.013 M TFA solution at pH 2.0, and 0.01 M HCl solu-
tion at pH 2.0, respectively, at the peptide concentration of
1 g/L, using DLS. In Fig. 5 the measured average hydrody-
namic (or equivalent-sphere) radii, hRhi, are shown as a
function of the incubation time. In all three solutions, the
hRhi value of the fibrils increases with time slowly, indi-
cating the occurrence of slow aggregation of the fibrils.
The aggregation rate in the three solutions follows the order,
0.013 M TFA at pH 2.0 > 0.01 M HCl at pH 2.0 > water at
pH 4.5. Because the isoelectric point of RADA 16-I is pI ¼Biophysical Journal 102(7) 1617–16267.2 (10), at both pH 4.5 and 2.0 the net charge on the surface
is positive. The net charges of RADA16-I monomer calcu-
lated from the pK values of the amino acid side chains
(38) are about þ0.75 at pH 4.5 and þ4 at pH 2.0, and, in
fact, the zeta potential values are 36.2 mV in water at pH
4.5 and 40.8 mV in 0.013 M TFA at pH 2.0 (details of
zeta potential measurements are reported in the Supporting
Material). Therefore, the better stability of the fibril disper-
sion in water at pH 4.5 cannot be explained by the charging
effect. We believe that it results from the hydrophobic
effect. In particular, at pH 2.0 more aspartic residues are
protonated, leading to an increase in the hydrophobicity of
the peptide, thus in the propensity to aggregation in water.
TFA is a strong counterion-pairing agent (39) and has a
larger propensity to bind charged groups with respect to
Cl (see Fig. S2). The larger aggregation extent in the
0.013 M TFA solution than in the 0.01 M HCl solution at
pH 2.0 is consistent with the more efficient reduction of
the surface charges, thus promoting the aggregation, in
this case due to a charging effect.
For the fibril dispersion in water at pH 4.5, because negli-
gible monomers are present, the observed aggregation is
clearly due to fibril-fibril aggregation. In the 0.013 M TFA
and 0.01 M HCl solutions at pH 2.0, however, the character-
ization results shown in the previous section indicate that the
system contains a substantial amount of monomers. It would
then be reasonable to consider the participation of the mono-
mers in the aggregation, particularly considering that they
would be favored with respect to fibril-fibril aggregation
due to their higher diffusivity. However, after a detailed
SEC analysis of samples taken along the incubation time,
we found that although the amount of the monomers
decreases with time, several peaks at longer eluting times,
representing molecules smaller than RADA 16-I, appear
and increase with the incubation time, as clearly shown
in Fig. 6 a. Mass spectrometry analysis confirmed the
FIGURE 6 For the peptide distribution in the 0.01 M HCl solution at pH
2.0: (a) SEC chromatograms at several incubation times, where the peak at
the eluting time of 34 min represents the monomer, RADA 16-I, and (b)
percentage of the SEC chromatogram area corresponding to the remaining
monomers () and the fragments eluting at larger times (-).
FIGURE 7 AFM (a) and TEM (b) pictures of the fibrils in the RADA
16-I dispersion in the 0.013 M TFA solution at pH 2.0 and at the peptide
concentration of 1 g/L after 25 days incubation, and (c) fibril length distri-
butions obtained from the AFM pictures at time 0 (black) and after 25 days
incubation (white).
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molecules (Fig. S3). More importantly, as shown in Fig. 6
b, the area of the SEC chromatogram for the RADA 16-I
peak decreases and the total area for the smaller molecules
peaks increase as the incubation time increases, whereas the
area sum of all the peaks remains practically constant. These
results indicate that the decrease in the amount of monomers
along the incubation time is not due to aggregation to fibrils.
It is instead related to some chemical degradation of the
peptides (e.g., hydrolization) at low pH. On the other
hand, this result reveals that, similar to the case at pH 4.5,
the increase in the fibril size is also due to fibril-fibril
aggregation.
Samples at the incubation time of 25 days have been
analyzed by AFM and TEM, and the corresponding pictures
are shown in Fig. 7, a and b, respectively. The most impor-
tant observations from these pictures, as well as from the
fibril length distributions shown in Fig. 7 c, are that the
fibrils become longer but their diameter remains the same
as before the incubation. The same result has been found
for fibrils incubated in water at pH 4.5 for 5 months
(Fig. S4). This suggests that the main mechanism respon-sible for the fibril aggregation is the end-to-end fibril elon-
gation, and that lateral aggregation is negligible. Such
mechanism is consistent with the sliding diffusion dynamic
reassembly proposed by Yokoi and co-workers for the
RADA 16-I fibril aggregation (27). They showed that after
sonication and breakage of longer fibrils, the fragmented
fibrils reassemble into the original fibrils, due to the un-
paired hydrophobic and hydrophilic patches at the end of
the fibril created by the breakage.
The previous results have been confirmed by incubation
at higher temperatures to accelerate the aggregation. AsBiophysical Journal 102(7) 1617–1626
1624 Arosio et al.can be seen from Fig. 8, increasing temperature induces
both faster aggregation kinetics and faster peptide
degradation.
Let us now apply the Smoluchowski kinetic approach, i.e.,
the population balance equations (PBE), to simulate the
growthof thefibrils, based on the end-to-endfibril-fibril aggre-
gation mechanism. The PBE in this case can be written as
dNi
dt
¼ 1
2
Xi1
j¼ 1
kj;ijNjNij  Ni
XN
j¼ 1
kijNj; (11)
where Ni is the number concentration of fibrils with length i,
and kij the rate constant for the aggregation between two
fibrils with length i and j, respectively. The first and the
second terms on the right side of Eq. 11 represent the birth
and death of the fibril of a given length, respectively. The
aggregation rate constant can be expressed as
kij ¼ a$kDiffij ; (12)
where kDiffij is the rate constant for diffusion-limited aggrega-
tion and a (˛[0,1]) is a parameter representing the efficiencyFIGURE 8 (a) Measured time evolutions of the average hydrodynamic
radius, hRhi, of the fibrils in the 0.013 M TFA solution at pH 2.0 at T ¼
4C (,), 25C (:), 37C (B), and 50C (A), compared with the PBE
simulations (solid curves) based on Eq. 11, and (b) area percentage of the
remaining monomers (open symbols) and the corresponding fragments
(solid symbols) at 37C (B and ,) and 50C (> andA).
Biophysical Journal 102(7) 1617–1626of the aggregation with respect to the diffusion-limited
aggregation. Following Hill (40) and Pallitto and Murphy
(41), kDiffij for the end-to-end fibril aggregation can be ex-
pressed as
kDiffij ¼
kBT
3h
NA
1000
ðd$uÞ2
Li þ Lj

lnðLi=bÞ þ ni
Li
þ ln

Lj=b
þ nj
Lj

;
ni ¼ 0:312þ 0:565ðLi=bÞ10:100ðLi=bÞ2;
(13)where T is temperature, kB the Boltzmann constant, NA
the Avogadro number, h the viscosity of the solvent, u the
minimum allowed angle between two fibrils, and d the
minimum allowed distance between two fibrils. A reference
value from the literature was used for d$u (¼ 4.5  1010
cm rad) (42), and it was assumed temperature independent.
The parameter a in Eq. 12 was used as an adjustable param-
eter to reproduce the experimental fibril length distributions
(see the Supporting Material for details).
By numerical integration of the PBE, we obtain the time
evolution of the fibril distribution, from which the corre-
sponding average hydrodynamic radius, hRhi, can be evalu-
ated from the average diffusion coefficient, hDiz, calculated
according to Eq. 6. The fibril distribution estimated from the
AFM pictures in Fig. 1 b has been considered as the initial
condition. The simulated curves are compared with the
experimental data at different aggregation temperatures in
Fig. 8 a. It can be seen that the model simulation results
are in good agreement with the experimental data when
the fibrils are small. As the fibril length increases, due to
the fibril flexibility, bending, curvature, etc., the fibrils
cannot be modeled as rod-like objects. As a consequence,
the expressions of the Rh and of the aggregation rate consid-
ered in the model do not apply anymore, and the simulation
results deviate significantly from the experimental data.
The a-values obtained from the simulations at different
conditions are summarized in Table 1: all of them are
substantially smaller than unity, indicating that all the inves-
tigated aggregation processes are substantially slower than
diffusion-limited aggregation. Thus, the aggregation rate is
not controlled by diffusion but rather an activated process
that requires the overcoming of some activation energy
barrier. This is estimated to be in the order of 20 kcal/mol
by considering the Arrhenius-type behavior of k11
(Eq. 12): k11 ¼ k0 expðEAtt=RTÞ, as shown in Fig. S6.TABLE 1 a-Values in Eq. 12 estimated by fitting the
experimental aggregation kinetics data
Solution type
Temperature
4C 25C 37C 50C
0.013 M TFA at pH 2.0 1.0  105 6.0  105 1.1  104 5.0  104
0.01 M HCl at pH 2.0 4.6  105
water at pH 4.5 2.7  106
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In this work, we have investigated the dispersion behavior
of the RADA 16-I peptide powder in various aqueous
solutions. First of all, using several microscopy and LS
techniques, we have identified the existence of stable
RADA 16-I nanofibrils in the pH range of 2.0–4.5. Such
fibrils show a b-sheet structure and have length of around
200–400 nm and diameter of 10 nm. The latter would indi-
cate that each fibril is constituted of two filaments of
stretched monomer aligned laterally. These small fibrils
cannot be broken by the mechanical stress generated from
sonication.
When the peptide powder is dispersed in water at pH 4.5
at a concentration of 1 g/L, all the peptides are in the form of
fibrils with an undetectable amount of monomers. When it is
dispersed in the 0.013 M TFA or 0.01 M HCl solution at pH
2.0, however, the dispersion contains a substantial amount
of monomers. FTIR data indicate that the peptides in the
powder are already in the form of fibrils, and the monomers
at pH 2.0 arise from dissolution of the fibrils induced by the
presence of TFA or Cl.
The stability of the fibril dispersions in water with respect
to their incubation time has been investigated at the peptide
concentration of 1 g/L. It is found that very slow end-to-end
aggregation of the fibrils occurs, leading to elongation of the
fibrils without changing their diameter. It has been observed
that the monomers do not participate in the fibril elongation.
The elongation rate is faster for the peptide dispersion in the
presence of TFA or Cl at pH 2.0 than in pure water at pH 4.5,
indicating the effect of pH and nature of the anions. The
aggregation can be accelerated by temperature in the range
of 4–50C.
The aggregation kinetics under different conditions has
been simulated by the Smoluchowski kinetic model, PBE,
considering the fibrils to be rod-like. Good agreement
between simulations and experiments has been obtained
when the incubation time is short, but significant deviation
occurs at a long incubation time, where the fibrils most
likely grow too long to be considered as rod-like.
It is also found that the aggregation process is not limited
by diffusion but rather is an activated process with an energy
barrier in the order of 20 kcal/mol.SUPPORTING MATERIAL
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